Krzyzanski W[au] - Search Results

Year	Number of Results
1997	2
1998	4
1999	3
2000	2
2001	3
2002	4
2003	1
2004	2
2005	3
2006	7
2007	10
2008	6
2009	6
2010	8
2011	4
2012	6
2013	6
2014	5
2015	5
2016	3
2017	3
2018	5
2019	4
2020	3
2021	7
2022	2

1

Special issue: chronopharmacometrics.

Krzyzanski W. Krzyzanski W. J Pharmacokinet Pharmacodyn. 2021 Jun;48(3):319-320. doi: 10.1007/s10928-021-09759-8. Epub 2021 May 7. J Pharmacokinet Pharmacodyn. 2021. PMID: 33963472 No abstract available.

2

Special issue: mathematical pharmacology.

Krzyzanski W, van Hasselt JGC. Krzyzanski W, et al. J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):1. doi: 10.1007/s10928-017-9566-5. Epub 2018 Jan 3. J Pharmacokinet Pharmacodyn. 2018. PMID: 29299711 No abstract available.

3

Delay differential equations based models in NONMEM.

Yan X, Bauer R, Koch G, Schropp J, Perez Ruixo JJ, Krzyzanski W. Yan X, et al. Among authors: krzyzanski w. J Pharmacokinet Pharmacodyn. 2021 Dec;48(6):763-802. doi: 10.1007/s10928-021-09770-z. Epub 2021 Jul 23. J Pharmacokinet Pharmacodyn. 2021. PMID: 34302262

4

Pharmacodynamic models of age-structured cell populations.

Krzyzanski W. Krzyzanski W. J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):573-89. doi: 10.1007/s10928-015-9446-9. Epub 2015 Sep 16. J Pharmacokinet Pharmacodyn. 2015. PMID: 26377617 Review.

5

Lifespan based indirect response models.

Krzyzanski W, Perez Ruixo JJ. Krzyzanski W, et al. J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):109-23. doi: 10.1007/s10928-011-9236-y. Epub 2012 Jan 3. J Pharmacokinet Pharmacodyn. 2012. PMID: 22212685 Free PMC article. Review.

6

Population Model of Serum Creatinine as Time-Dependent Covariate in Neonates.

Krzyzanski W, Smits A, Van Den Anker J, Allegaert K. Krzyzanski W, et al. AAPS J. 2021 Jun 17;23(4):86. doi: 10.1208/s12248-021-00612-x. AAPS J. 2021. PMID: 34142253

7

Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Doshi S, Krzyzanski W, Yue S, Elliott S, Chow A, Pérez-Ruixo JJ. Doshi S, et al. Among authors: krzyzanski w. Clin Pharmacokinet. 2013 Dec;52(12):1063-83. doi: 10.1007/s40262-013-0098-x. Clin Pharmacokinet. 2013. PMID: 23912564 Review.

8

A quantitative systems pharmacology model of hyporesponsiveness to erythropoietin in rats.

Nguyen LM, Li Z, Yan X, Krzyzanski W. Nguyen LM, et al. Among authors: krzyzanski w. J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):687-710. doi: 10.1007/s10928-021-09762-z. Epub 2021 Jun 7. J Pharmacokinet Pharmacodyn. 2021. PMID: 34100188

9

Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy.

Woot de Trixhe X, Krzyzanski W, Vermeulen A, Perez-Ruixo JJ. Woot de Trixhe X, et al. Among authors: krzyzanski w. CPT Pharmacometrics Syst Pharmacol. 2021 Aug;10(8):826-838. doi: 10.1002/psp4.12604. Epub 2021 Jul 23. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34296543 Free PMC article.

10

Age-structured population model of cell survival.

Krzyzanski W, Wiczling P, Gebre A. Krzyzanski W, et al. J Pharmacokinet Pharmacodyn. 2017 Aug;44(4):305-316. doi: 10.1007/s10928-017-9520-6. Epub 2017 Mar 29. J Pharmacokinet Pharmacodyn. 2017. PMID: 28357630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results